Videos | Cath Lab | March 28, 2017

MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017...

Philips Azurion angiography system, FFR for STEMI
Feature | Cath Lab | March 27, 2017

March 27, 2017 — Patients experiencing a major heart attack often have more than one clogged artery, but under...

Videos | Heart Valve Technology | March 24, 2017

Michael Reardon, M.D., professor of cardiothoracic surgery at Houston Methodist DeBakey Heart and Vascular Center,...

Philips, cardiology solutions, ACC.17, Azurion angiography system, iFR outcomes results, IntelliSpace Cardiovascular
News | Cardiac Imaging | March 24, 2017

March 24, 2017 — At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips...

Videos | FFR Catheters | March 23, 2017

Justin Davies, MBBS, of Imperial College London, and Matthias Götberg, M.D, Ph.D., of Skane University Hospital,...

rivaroxaban, asprin, venous thromboembolism, VTE recurrence, clinical study, ACC.17
News | Antiplatelet and Anticoagulation Therapies | March 23, 2017

March 23, 2017 — In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low...

microbleeds, brain bleeds caused by TAVR

An MRI brain scan showing multiple microbleeds in a transcatheter aortic valve replacement (TAVR) patient from the study.

Feature | Heart Valve Technology | March 23, 2017

March 22, 2017 — A quarter of the patients in a single-center study of 84 patients undergoing transcatheter aortic...

Cardiogard embolic protection system for surgical valve reaplacement

The CardioGard embolic protection system for surgical aortic valve replacement.

Feature | Embolic Protection Devices | March 22, 2017

March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove...

Medtronic Corevalve Evolut Pro, TAVR system
Feature | Heart Valve Technology | March 22, 2017

March 22, 2017 – The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve...

Videos | Hemodynamic Support Devices | March 21, 2017

The Abiomed Impella percutaneous ventricular assist devices (pVAD) offer between 2.5 and 5 liters of flow per minute...

BVS, Absorb stent, bioresorbable scaffold, ABSORB III data, ABSORB III results
Feature | Stents Bioresorbable | March 21, 2017 | Dave Fornell

 

March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College...

Technology | Guidewires | March 20, 2017

March 20, 2017 — Teleflex Inc. recently announced 510(k) clearance by the U.S. Food and Drug Administration (FDA)...

iFR, iFR vs. FFR, ACC late breaking trial, iFR-SWEDEHEART, DEFINE-FLAIR, Justin E. Davies,

Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions. 

Feature | FFR Catheters | March 20, 2017

March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR...

Evolocumab, Repatha, LDL, ACC late breaker, best LDL lowering drug
Feature | Pharmaceuticals | March 20, 2017

March 20, 2017 — The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology...

Michael Reardon, SURTAVI, TAVR equals surgery in intermediate risk patients

SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017. 

News | Heart Valve Technology | March 17, 2017 | Dave Fornell

March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...

Overlay Init